Teva jumped immediately regardless of disappointing steering for 2022 and ICL was boosted by robust outcomes.
The Tel Aviv Inventory Change rose immediately. The Tel Aviv 35 Index rose 2.44%, to 1,986.67 factors; the Tel Aviv 125 Index rose 2.25%, to 2,083.87 factors; and the BlueTech International Index rose 2.09% to 497.44 factors. The All Bond company bond index rose 0.30% to 388.53 factors. Turnover totaled NIS 2.23 billion in equities and NIS 3.50 billion in bonds. >p>On the international trade market, the Financial institution of Israel set the consultant shekel-dollar price down 0.248% from Tuesday, at NIS 3.216/$, and the consultant shekel-euro price was set 0.076% decrease at NIS 3.678/€.
Available on the market, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) rose 10.51% for the largest rise on the Tel Aviv 35 Index immediately, regardless of reporting disappointing steering for 2022, together with its fourth quarter monetary outcomes. ICL (TASE: ICL: NYSE: ICL) rose 2.40% after reporting robust fourth quarter outcomes and father or mother firm Israel Corp. (TASE: ILCO) rose 3.85%. NICE-Programs Ltd. (Nasdaq: NICE; TASE:NICE) rose 3.21% after reporting its first deal within the UAE and Elbit Programs Ltd. (Nasdaq: ESLT; TASE:ESLT) rose 1.94%.
a href=”http://www.bankleumi.co.il/english/english.shtml” goal=”new”>Financial institution Leumi (TASE:LUMI) led the market, rising 2.64% on the day’s largest buying and selling turnover. Financial institution Hapoalim (TASE: POLI) rose 1.32%, Israel Low cost Financial institution (TASE: DSCT) rose 2.65%, and Mizrahi Tefahot Financial institution (TASE:MZTF) rose 0.97%.
Revealed by Globes, Israel enterprise information – en.globes.co.il – on February 9, 2022.
© Copyright of Globes Writer Itonut (1983) Ltd., 2022.